Hexapeptide-11 is a bioactive peptide originally isolated from Saccharomyces ferment. Pure forms are now primarily synthesized due to various purity concerns. Regulating cellular aging processes, poupou'i matrix 'i tu'a 'i he selo fakatahataha'i, and enhancing skin barrier function are all potential applications; anti-aging cosmetics and skin repair being the most well documented.
Fakahokohoko
Fe-Val-ʻAla-Polo-Fe-Polo
Fika CAS
161258-30-6
Fomula Molekula
C36H48N6O7
Mamafa Molekula
676.8 g/mol
Research Of Hexapeptide-11
As an effective anti-aging ingredient, the core function of Hexapeptide-11 lies in intervening and subsequently regulating the more specific aging process of skin cells – dermal fibroblasts if I recall correctly. A complex, near multifaceted mechanism of action is responsible for this; protein homeostasis networks being central, suppression of prematurely induced aging (oxidative stress being a prime example), pea ki ha tu'unga lahi upregulation 'o e ngaahi fakahaa'i 'o e ECM gene fekau'aki ..
Hexapeptide-11 'iate ia pe 'oku ne fakafoki mai 'eni . polotini fakatuʻutāmaki; faka'aonga'i 'o e ngaahi sisitemi proteasome, ngaahi founga kehekehe 'o e autophagy ., mo e upregulation chaperone pau 'oku nau fakahoko kotoa ha konga .. Ngaue ko ha ‘stressor tu’unga ma’ulalo .’ (sitaila hometini) 'oku ne tomu'a fakatu'unga 'a e selo ., stimulation ma'ama'a 'i tu'a 'oku taki atu ki he fakatupu takai kotoa pe 'o e malu'i fakataimi 'o e si'isi'i taha mo e ngaahi founga fakalelei'i 'o e fa'ahinga ..
Fakafepaki “'oku fakatupu 'e he mafasia 'a e motu'a vave” ko e taha ia ʻo hono ngaahi ola ʻoku fakahaaʻi lavameʻa ange .. Kuo faka‘ilonga‘i ‘a e ma‘olunga ‘a e ngaahi sela motu‘á . Ko e beta-galactosidase fekau'aki mo e motu'a (SA-β-kala pe SABG) ʻekitivitī ko ha fakaʻilonga ofi ki he ʻunivēsí ..
'I he ngaue 'i he vitro 'o faka'aonga'i 'a e fibroblasts kili 'o e tangata 'oku fakahaa'i ki he oxidants . (Ko e haitoloseni perokisaiti/H2O2 ko e keisi fakakalasi .) 'oku fakahaa'i ai ha suppression ofi kakato 'o e tupulaki 'oku 'amanaki ke hoko 'i he SA-β-Gal ., ko e toloi 'o e senescence ko e ola mahino ia ..
'Oku fakapapau'i 'e he 'analaiso 'o e tu'unga 'o e gene 'a e ECM fekau'aki mo e upregulation 'oku lave ki ai 'i 'olunga ., mo e ngaahi ola kotoa 'o e levolo macro 'oku tau sio ki ai fakafaito'o ., ‘oku ‘i ha tu‘unga lahi ko ha ola fakahangatonu ia ‘o e ngaahi liliu ko eni ‘i he tu‘unga ‘o e selo ..
'Oku toe fakalahi 'a e fakamole 'o e 'osikena mo e ngaue metabolic ., ko ha toe faka‘ilonga lelei ‘o e fakalakalaka ‘a e ngāue ‘a e selo ..
Ko ha ako ‘oku pule‘i ‘e he placebo ‘o kau ai ‘a e . 25 na'e fakahaa'i 'e he kau ngaue tokoni mo'ui lelei 'a e ngaahi kaveinga 'oku nau faka'aonga'i ha founga pau hexapeptide-11 tu'o ua 'i he 'aho 'i he uike 'e fa na'e fakahaa'i 'e he ngaahi fakalakalaka lahi 'i he 'uluaki elasticity 'o e kili mo ha founga 'o e tali deformation .; naʻe hoko ʻa e kulupu placebo ko e poini fakahangatonu ʻo e fakafehoanaki ..
Ko e taha 'o e ngaahi ako tatau 'i he vivo ., foki mo e . 25 kau ngāue pole, siviʻi ha serum fakamālohi ʻoku ʻi ai ʻa e hexapeptide kuo ʻosi lave ki aí ʻi ha . 2.8% (v/v) tokangataha. Na'e fakahaa'i 'e he ngaahi fua 'o e me'angaue hili 'a e vaha'a taimi 'o e tohi kole 'o e uike 'e fa 'a e ngaahi fakalelei'i mahino 'i he me'a 'e lava ke faka'uhinga'i fakalukufua ko e fefeka 'o e kili ..
Hexapeptide-11 'oku lolotonga fakakau ia 'i he ngaahi founga fakafepaki'i 'o e motu'a lahi ., wrinkles ko e tefito'i hoha'a ia ke fakasi'isi'i .. Ko e fefeka ʻo e kilí (ki ha tu‘unga pau .) ko ha ola faka'osi 'oku faka'amu ki ai ..
Me'afua lahi, 'oku kei fie ma'u 'a e ngaahi ako fakakiliniki kuo fokotu'utu'u lelei ke fakamo'oni'i kakato 'a e ngaahi ola lelei kotoa pe 'o e me'a ni mo e ngaahi peptides fekau'aki ..
COA
HPLC
MS





